ABOUT half of men and 40 per cent of women will experience some form of hair loss by the age of 50, according to the National ...

However, a new drug may finally change all that. Veradermics, a Connecticut-based biopharmaceutical company, is developing a ...

FoLix, the FDA-cleared laser treatment for hair loss, provides a surgery-free option and uses existing follicles on men and ...

Pelage Pharmaceuticals said on Wednesday it had closed a $120 million funding round to help advance the development of its ...

If you're struggling with hair loss or baldness, this news may be a welcome relief. Scientists have developed a new serum ...

The latest strand in Pelage Pharmaceuticals’ growing funds comes from a $120 million series B fundraising round that the ...

There are many options for treating hair loss, including natural remedies, over-the-counter topical treatments, laser therapy ...

A leading treatment for androgenetic alopecia (AGA) – the classic pattern hair loss – could be made more effective with the ...

Veradermics locked in a new layer of funding with a $150 million series C financing round that will support its ambitions of ...

Androgenetic alopecia is a common form of hair loss in both men and women—also called male pattern baldness and female ...

Chemotherapy-induced alopecia​ is one of the most common and distressing side effects of chemotherapy. Scalp cooling is a ...